Axalimogene Filolisbac for Platinum-Refractory Cervical Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Gynecologic Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase II Study of Axalimogene Filolisbac (ADXS-HPV) for Platinum-Refractory Cervical Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study
Gynecol. Oncol 2020 Jul 05;[EPub Ahead of Print], WK Huh, WE Brady, PM Fracasso, DS Dizon, MA Powell, BJ Monk, CA Leath, LM Landrum, EJ Tanner, EK Crane, S Ueda, MT McHale, C AghajanianFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.